Investment and Economic Review - SMSF - MDA - SMA - Sydney - Melbourne
Privacy Policy · Disclaimer · FSG
F Palmer & ME Palmer
Trading as Joseph Palmer & Sons
AFS Licence 247067 · ABN 29 548 490 818

Palmer Articles

No articles found with the specified search parameters. Return

Investment & Economic Review October 2021

18 Oct 2021

Regrettably, the COVID pandemic took a turn for the worse in Australia, with higher community transmission and consequential societal and business restrictions and lockdowns. This has caused some meaningful reduction in present economic activity, though a clearer roadmap to reopening and recovery is now apparent, likely leading to a sharp rebound in activity in 2022.

Investment & Economic Review July 2021

23 Jul 2021

Multiple schemes and strategies have been employed by governments and central banks since the pandemic began, and these have largely been successful in mitigating the economic downturn risks, which otherwise would have been more significant.

Investment & Economic Review April 2021

21 Apr 2021

The Reserve Bank of Australia (RBA) conducts monetary policy meetings on the first Tuesday of each month. The pronouncements and policy settings from these meetings have become increasingly important due to the RBA’s particularly aggressive monetary actions and interest rate control interventions. 

Investment & Economic Review January 2021

27 Jan 2021

Financial market observers, investors and analysts can be forgiven for being perplexed, as longstanding and normal logic was disregarded in the second half of 2020 – remarkably, share and real estate prices actually rose despite the recession, depressed earnings, global pandemic and political turbulence.

Investment & Economic Review October 2020

15 Oct 2020

More than half a year has passed since the global pandemic wreaked havoc in societies and financial markets worldwide. Regrettably, the virus remains virulent so has slowed the pace of economic recovery and caused a multitude of social implications to remain prominent. The path towards a vaccine seems promising, with more than 130 projects globally, funded almost limitlessly, with accelerated clinical trial processes. A rapid rebound in consumer confidence and associated economic activity is expected should a successful vaccine become widely available.

123456Last

Full name*
Email*
Phone number*
Message*
.
Slide To Submit
»
Please fill out the form and slide to submit